- Home
- AMS vs NNVC Comparison
AMS vs NNVC Comparison
Compare AMS & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMS
- NNVC
- Stock Information
- Founded
- AMS 1980
- NNVC 2005
- Country
- AMS United States
- NNVC United States
- Employees
- AMS 13
- NNVC N/A
- Industry
- AMS Medical Specialities
- NNVC Biotechnology: Pharmaceutical Preparations
- Sector
- AMS Health Care
- NNVC Health Care
- Exchange
- AMS Nasdaq
- NNVC Nasdaq
- Market Cap
- AMS 19.3M
- NNVC 22.0M
- IPO Year
- AMS N/A
- NNVC N/A
- Fundamental
- Price
- AMS $3.01
- NNVC $1.50
- Analyst Decision
- AMS
- NNVC Strong Buy
- Analyst Count
- AMS 0
- NNVC 1
- Target Price
- AMS N/A
- NNVC $6.50
- AVG Volume (30 Days)
- AMS 4.3K
- NNVC 323.3K
- Earning Date
- AMS 03-26-2025
- NNVC 02-14-2025
- Dividend Yield
- AMS N/A
- NNVC N/A
- EPS Growth
- AMS 779.12
- NNVC N/A
- EPS
- AMS 0.61
- NNVC N/A
- Revenue
- AMS $24,969,000.00
- NNVC N/A
- Revenue This Year
- AMS $27.74
- NNVC N/A
- Revenue Next Year
- AMS $17.72
- NNVC N/A
- P/E Ratio
- AMS $4.96
- NNVC N/A
- Revenue Growth
- AMS 20.83
- NNVC N/A
- 52 Week Low
- AMS $2.51
- NNVC $1.03
- 52 Week High
- AMS $4.60
- NNVC $3.59
- Technical
- Relative Strength Index (RSI)
- AMS 45.88
- NNVC 63.26
- Support Level
- AMS $2.88
- NNVC $1.30
- Resistance Level
- AMS $3.10
- NNVC $1.47
- Average True Range (ATR)
- AMS 0.06
- NNVC 0.11
- MACD
- AMS -0.01
- NNVC 0.04
- Stochastic Oscillator
- AMS 40.33
- NNVC 88.37
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.